Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China flag China · Delayed Price · Currency is CNY
22.28
+0.08 (0.36%)
Jul 31, 2026, 3:00 PM CST

SHA:600332 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
12,32814,94018,27321,30922,50022,377
Short-Term Investments
-8,8614,446729.162,117-
Trading Asset Securities
44-456.87-
Cash & Short-Term Investments
12,33223,80522,71922,04224,67322,377
Cash Growth
-33.49%4.78%3.07%-10.66%10.26%14.61%
Accounts Receivable
25,68020,94019,45619,59819,16817,211
Other Receivables
1,3581,186993.65882.35920.511,276
Receivables
27,03822,12620,44920,48020,08818,486
Inventory
12,46913,13812,81211,50710,67210,438
Other Current Assets
13,2272,4491,7821,9551,6311,510
Total Current Assets
65,06561,51857,76255,98457,06452,811
Property, Plant & Equipment
8,4428,3657,9397,5166,5705,684
Long-Term Investments
10,3718,79310,1469,4525,8972,891
Goodwill
919.94834.09830.85829.47829.47829.47
Other Intangible Assets
3,1723,1812,8292,8862,5852,582
Long-Term Deferred Tax Assets
1,2551,2861,2101,164865.34794.23
Long-Term Deferred Charges
155.82162.47558.49499.77407.47143.05
Other Long-Term Assets
377.55370.9407.77256.22446.54382.46
Total Assets
89,75884,51181,68478,58774,66566,118

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
18,28317,57116,32015,68614,96114,733
Accrued Expenses
770.643,5693,6733,6513,4843,478
Short-Term Debt
11,8159,8609,1237,7999,1468,428
Current Portion of Long-Term Debt
1,4072,0271,33236.45498.5830.03
Current Portion of Leases
-185.2190.57213.38208.15215.77
Current Income Taxes Payable
561.66170.9118.4249.26237143.41
Current Unearned Revenue
1,2972,8335,0725,4305,6442,740
Other Current Liabilities
6,6292,9093,0883,1703,2162,485
Total Current Liabilities
40,76339,12538,91636,23537,39532,254
Long-Term Debt
4,8593,1742,8063,3241,639752.81
Long-Term Leases
367.01371.47445.72578.19545.84497.7
Long-Term Unearned Revenue
1,0821,0421,0021,001930.93826.86
Pension & Post-Retirement Benefits
0.290.290.30.290.320.3
Long-Term Deferred Tax Liabilities
598.33599.37625.56639.53394.59331.73
Other Long-Term Liabilities
194.41116.74119.31130.6121.45127.87
Total Liabilities
47,86544,42843,91441,90941,02734,791

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,6261,6261,6261,6261,6261,626
Additional Paid-In Capital
10,32410,32410,11410,10610,1069,957
Retained Earnings
27,64525,86124,17923,21220,34717,497
Comprehensive Income & Other
-33.34-22.6-13.84-24.34-12.9-17.48
Total Common Equity
39,56137,78835,90534,91932,06529,062
Minority Interest
2,3322,2951,8651,7591,5732,264
Shareholders' Equity
41,89340,08337,77036,67833,63831,327
Total Liabilities & Equity
89,75884,51181,68478,58774,66566,118

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
18,44815,61713,89711,95112,0389,924
Net Cash (Debt)
-6,1178,1888,82310,09112,63512,453
Net Cash Growth
--7.20%-12.57%-20.14%1.47%24.99%
Net Cash Per Share
-3.765.045.436.217.777.66
Filing Date Shares Outstanding
1,6261,6261,6261,6261,6261,626
Total Common Shares Outstanding
1,6261,6261,6261,6261,6261,626
Working Capital
24,30222,39418,84719,74819,66920,557
Book Value Per Share
24.3323.2422.0821.4819.7217.88
Tangible Book Value
35,46933,77332,24531,20328,65125,650
Tangible Book Value Per Share
21.8220.7719.8319.1917.6215.78
Buildings
-6,4645,2134,3283,6303,317
Machinery
-5,5215,1064,4164,0253,582
Construction In Progress
-1,1501,8462,4052,1081,564